Multiple endocrine neoplasia type 2 other diagnostic studies: Difference between revisions
(Mahshid) |
|||
(3 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{Multiple endocrine neoplasia type 2}} | {{Multiple endocrine neoplasia type 2}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Other diagnostic studies for multiple endocrine neoplasia type 2 include molecular [[genetic testing]] which include sequence analysis of select exons of mainly 10,11, 13-16 and sequence analysis of [[RET proto-oncogene|''RET'' gene]]. | Other diagnostic studies for multiple endocrine neoplasia type 2 include molecular [[genetic testing]] which include sequence analysis of select exons of mainly 10,11, 13-16 and sequence analysis of [[RET proto-oncogene|''RET'' gene]]. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
===Molecular Genetic Testing=== | ===Molecular Genetic Testing=== | ||
Line 28: | Line 30: | ||
| pmid = 020301434 | | pmid = 020301434 | ||
}}</ref> | }}</ref> | ||
# [[Calcitonin]]: positive in [[tumor]] [[cell]]s | |||
# [[Chromogranin]]: positive in [[tumor]] [[cell]]s | |||
# [[Synaptophysin]]: positive in [[tumor]] [[cell]]s | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Oncology]] | |||
[[Category:Diseases]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] |
Latest revision as of 02:47, 27 November 2017
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 other diagnostic studies On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 other diagnostic studies |
FDA on Multiple endocrine neoplasia type 2 other diagnostic studies |
CDC on Multiple endocrine neoplasia type 2 other diagnostic studies |
Multiple endocrine neoplasia type 2 other diagnostic studies in the news |
Blogs on Multiple endocrine neoplasia type 2 other diagnostic studies |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Other diagnostic studies for multiple endocrine neoplasia type 2 include molecular genetic testing which include sequence analysis of select exons of mainly 10,11, 13-16 and sequence analysis of RET gene.
Other Diagnostic Studies
Molecular Genetic Testing
Test | Method |
---|---|
Select exon testing | Sequence analysis of select exons of mainly 10,11, 13-16 |
Single-gene testing | Sequence analysis of RET gene |
A multi-gene panel | RET and other genes of interest |
Histopathological Staining of the Biopsy
- Histopathological staining of medullary thyroid cancer[1]
- Calcitonin: positive in tumor cells
- Chromogranin: positive in tumor cells
- Synaptophysin: positive in tumor cells
References
- ↑ Jessica Marquard & Charis Eng (1993). "Multiple Endocrine Neoplasia Type 2". PMID 020301434.